NEW YORK (GenomeWeb News) - Ohio State University will make available a SELDI-based hematology test made by Vermillion, the company said today.
 
Vermillion, formerly known as Ciphergen, said OSU will license the homebrew test for managing patients with the blood-clotting disorder thrombotic thrombocytopenic purpura. The test was co-developed with the school’s University Research Foundation.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.